143 related articles for article (PubMed ID: 25273169)
1. Upregulation of mediator MED23 in non-small-cell lung cancer promotes the growth, migration, and metastasis of cancer cells.
Shi J; Liu H; Yao F; Zhong C; Zhao H
Tumour Biol; 2014 Dec; 35(12):12005-13. PubMed ID: 25273169
[TBL] [Abstract][Full Text] [Related]
2. Serum and glucocorticoid kinase 1 promoted the growth and migration of non-small cell lung cancer cells.
Xiaobo Y; Qiang L; Xiong Q; Zheng R; Jianhua Z; Zhifeng L; Yijiang S; Zheng J
Gene; 2016 Jan; 576(1 Pt 2):339-46. PubMed ID: 26548813
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of SRPK1 in non-small cell lung cancer promotes the growth and migration of cancer cells.
Liu H; Hu X; Zhu Y; Jiang G; Chen S
Tumour Biol; 2016 Jun; 37(6):7287-93. PubMed ID: 26666824
[TBL] [Abstract][Full Text] [Related]
4. Selective requirement for Mediator MED23 in Ras-active lung cancer.
Yang X; Zhao M; Xia M; Liu Y; Yan J; Ji H; Wang G
Proc Natl Acad Sci U S A; 2012 Oct; 109(41):E2813-22. PubMed ID: 22988093
[TBL] [Abstract][Full Text] [Related]
5. YEATS4 promotes the tumorigenesis of pancreatic cancer by activating beta-catenin/TCF signaling.
Jixiang C; Shengchun D; Jianguo Q; Zhengfa M; Xin F; Xuqing W; Jianxin Z; Lei C
Oncotarget; 2017 Apr; 8(15):25200-25210. PubMed ID: 28445953
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Ubiquitin-Specific Peptidase 17 (USP17) Inhibits Tumorigenesis and Invasion in Non-Small Cell Lung Cancer Cells.
Zhang S; Yuan J; Zheng R
Oncol Res; 2016; 24(4):263-9. PubMed ID: 27656837
[TBL] [Abstract][Full Text] [Related]
7. HEPACAM inhibited the growth and migration of cancer cells in the progression of non-small cell lung cancer.
Shao H; Gu Y; Ding J; Lu P; Ruan T; Lu W
Tumour Biol; 2016 Feb; 37(2):2621-7. PubMed ID: 26392113
[TBL] [Abstract][Full Text] [Related]
8. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
9. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
10. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
11. Mediator subunit 23 overexpression as a novel target for suppressing proliferation and tumorigenesis in hepatocellular carcinoma.
Guo Y; Wang J; Li H; Liu W; Chen D; Zhao K; Liang X; Zhang Q; Yang Y; Chen G
J Gastroenterol Hepatol; 2015 Jun; 30(6):1094-103. PubMed ID: 25684393
[TBL] [Abstract][Full Text] [Related]
12. DYNC1H1 regulates NSCLC cell growth and metastasis by IFN-γ-JAK-STAT signaling and is associated with an aberrant immune response.
Pan H; Chai W; Liu X; Yu T; Sun L; Yan M
Exp Cell Res; 2021 Dec; 409(1):112897. PubMed ID: 34717919
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of MED23 promoted the tumorigenecity of esophageal squamous cell carcinoma.
Shi J; Han Q; Zhao H; Zhong C; Yao F
Mol Carcinog; 2014 Oct; 53(10):833-40. PubMed ID: 23625751
[TBL] [Abstract][Full Text] [Related]
14. LINC00184 plays an oncogenic role in non-small cell lung cancer via regulation of the miR-524-5p/HMGB2 axis.
Wang W; Li L; Zhao L
J Cell Mol Med; 2021 Nov; 25(21):9927-9938. PubMed ID: 34651416
[TBL] [Abstract][Full Text] [Related]
15. MED28 and forkhead box M1 (FOXM1) mediate matrix metalloproteinase 2 (MMP2)-dependent cellular migration in human nonsmall cell lung cancer (NSCLC) cells.
Hsieh NT; Huang CY; Li CC; Wang IC; Lee MF
J Cell Physiol; 2019 Jul; 234(7):11265-11275. PubMed ID: 30499104
[TBL] [Abstract][Full Text] [Related]
16. CircVAPA exerts oncogenic property in non-small cell lung cancer by the miR-876-5p/WNT5A axis.
Zhao Y; Dai Q; Fu X; Chen Q; Tang Y; Gao X; Zhou Q
J Gene Med; 2021 Jun; 23(6):e3325. PubMed ID: 33619796
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective.
Gao X; Cai Y; Wang Z; He W; Cao S; Xu R; Chen H
J Transl Med; 2019 Sep; 17(1):308. PubMed ID: 31511014
[TBL] [Abstract][Full Text] [Related]
18. MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer.
Li H; Lin PH; Gupta P; Li X; Zhao SL; Zhou X; Li Z; Wei S; Xu L; Han R; Lu J; Tan T; Yang DH; Chen ZS; Pawlik TM; Merritt RE; Ma J
Mol Cancer; 2021 Sep; 20(1):118. PubMed ID: 34521423
[TBL] [Abstract][Full Text] [Related]
19. Highly expressed lncRNA FOXD3-AS1 promotes non-small cell lung cancer progression via regulating miR-127-3p/mediator complex subunit 28 axis.
Zeng ZL; Zhu HK; He LF; Xu X; Xie A; Zheng EK; Ni JJ; Liu JT; Zhao GF
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2525-2538. PubMed ID: 32196603
[TBL] [Abstract][Full Text] [Related]
20. MED12 exerts an emerging role in actin-mediated cytokinesis via LIMK2/cofilin pathway in NSCLC.
Xu M; Wang F; Li G; Wang X; Fang X; Jin H; Chen Z; Zhang J; Fu L
Mol Cancer; 2019 May; 18(1):93. PubMed ID: 31072327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]